Market Cap 7.66B
Revenue (ttm) 521.31M
Net Income (ttm) -23.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4.48%
Debt to Equity Ratio 0.00
Volume 653,000
Avg Vol 1,088,686
Day's Range N/A - N/A
Shares Out 60.98M
Stochastic %K 99%
Beta 0.48
Analysts Strong Sell
Price Target $142.80

Company Profile

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally. The company is also involved in the commercializat...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 667 4085
Address:
989 East Hillsdale Boulevard, Suite 300, Foster City, United States
OffHisGame88
OffHisGame88 Jul. 4 at 2:39 PM
$MIRM seems interesting although I hate chasing biotech. Best to buy after a trial fail.
1 · Reply
Alpha_Ascendant
Alpha_Ascendant Jul. 4 at 11:29 AM
$MIRM Up 188% since my first report, this biotech is performing, building a liver disease franchise with a clutch of approved drugs while promising pipeline candidates --Volixibat, MRM-3379, Brelovitug, Zilurgisertib-- quietly stalk endpoints. $INCY ti.e-up and Bluejay acquisition a plus: https://seekingalpha.com/article/4919805-mirm-this-liver-disease-juggernaut-just-broadened-its-portfolio
0 · Reply
WAJeff
WAJeff Jul. 2 at 8:54 PM
$MIRM $125.75 ath
0 · Reply
IN0V8
IN0V8 Jul. 2 at 6:25 PM
$MIRM JP Morgan raises target price to $125 from $115
1 · Reply
LMXPERTEN
LMXPERTEN Jul. 2 at 1:50 PM
$MIRM so strong. Shaking the tree for losers.
0 · Reply
Hollywood_1
Hollywood_1 Jun. 29 at 1:33 AM
$MIRM another $XBI namd breaking out
0 · Reply
Doozio
Doozio Jun. 27 at 4:54 PM
👀 $MIRM $MEI da huckleberries r thru da $$$ as up da Roger yo go ENTA 🐒🍌🧠⏰♾️
0 · Reply
Home_Skillet
Home_Skillet Jun. 27 at 5:13 AM
$MIRM I still think we are undervalued been holding the bag since 22$ a share! Think we are heading North of 165$….
0 · Reply
CH_Expat
CH_Expat Jun. 26 at 6:47 PM
$MIRM Jesus Christ, I remember the duscussions which one is better, this or $ALBO. Case closed I would say. I was in ALBO BO and made my 70%, but most shareholders got just fckd there.
2 · Reply
WAJeff
WAJeff Jun. 26 at 3:00 PM
Had some $MIRM sell at $120, $123.10 ath
0 · Reply
Latest News on MIRM
Mirum Pharmaceuticals Slides: Corporate presentation

Jul 1, 2026, 7:00 AM EDT - 3 days ago

Mirum Pharmaceuticals Slides: Corporate presentation


Biotech ETF Index Surges 10% After Rebalance

Jun 25, 2026, 11:31 AM EDT - 9 days ago

Biotech ETF Index Surges 10% After Rebalance

ALKS APGE DFTX DYN KLRA KYMR MANE


Mirum Pharmaceuticals Slides: Study update presentation

Jun 13, 2026, 7:00 AM EDT - 21 days ago

Mirum Pharmaceuticals Slides: Study update presentation


Mirum Pharmaceuticals initiated with a Buy at Citi

2026-06-02T10:20:40.000Z - 4 weeks ago

Mirum Pharmaceuticals initiated with a Buy at Citi


Mirum Pharmaceuticals reports Q1 EPS ($13.43), consensus (35c)

2026-05-07T01:51:02.000Z - 2 months ago

Mirum Pharmaceuticals reports Q1 EPS ($13.43), consensus (35c)


Mirum Pharmaceuticals Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

Mirum Pharmaceuticals Earnings Call Transcript: Q1 2026


Mirum Pharmaceuticals Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

Mirum Pharmaceuticals Earnings release: Q1 2026


Mirum Pharmaceuticals Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

Mirum Pharmaceuticals Quarterly report: Q1 2026


Mirum Pharmaceuticals Slides: Corporate presentation

May 6, 2026, 7:00 AM EDT - 2 months ago

Mirum Pharmaceuticals Slides: Corporate presentation


Mirum Pharmaceuticals Transcript: Study result

May 4, 2026, 8:30 AM EDT - 2 months ago

Mirum Pharmaceuticals Transcript: Study result


Mirum Pharmaceuticals Slides: Study result

May 4, 2026, 8:30 AM EDT - 2 months ago

Mirum Pharmaceuticals Slides: Study result


Mirum Pharmaceuticals Press release: Study result

May 4, 2026, 8:30 AM EDT - 2 months ago

Mirum Pharmaceuticals Press release: Study result


Mirum Pharmaceuticals Slides: Corporate presentation

Apr 27, 2026, 7:00 AM EDT - 2 months ago

Mirum Pharmaceuticals Slides: Corporate presentation


Mirum Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 2 months ago

Mirum Pharmaceuticals Proxy statement: Proxy filing


Mirum Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 2 months ago

Mirum Pharmaceuticals Proxy statement: Proxy filing


Egetis Appoints Tiago Nunes as Chief Medical Officer

Apr 9, 2026, 1:15 AM EDT - 3 months ago

Egetis Appoints Tiago Nunes as Chief Medical Officer


Mirum Pharmaceuticals Slides: Corporate presentation

Mar 6, 2026, 6:00 AM EST - 4 months ago

Mirum Pharmaceuticals Slides: Corporate presentation


Mirum Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 25, 2026, 4:30 PM EST - 4 months ago

Mirum Pharmaceuticals Earnings Call Transcript: Q4 2025


Mirum Pharmaceuticals Annual report: Q4 2025

Feb 25, 2026, 4:30 PM EST - 4 months ago

Mirum Pharmaceuticals Annual report: Q4 2025


Mirum Pharmaceuticals Earnings release: Q4 2025

Feb 25, 2026, 4:30 PM EST - 4 months ago

Mirum Pharmaceuticals Earnings release: Q4 2025


Mirum Pharmaceuticals Slides: Corporate presentation

Feb 25, 2026, 7:00 AM EST - 4 months ago

Mirum Pharmaceuticals Slides: Corporate presentation


Mirum Pharmaceuticals Slides: Corporate presentation

Jan 12, 2026, 7:00 AM EST - 6 months ago

Mirum Pharmaceuticals Slides: Corporate presentation


Mirum Pharmaceuticals Transcript: M&A Announcement

Dec 8, 2025, 8:30 AM EST - 7 months ago

Mirum Pharmaceuticals Transcript: M&A Announcement


Mirum Pharmaceuticals Press release: M&A Announcement

Dec 8, 2025, 8:30 AM EST - 7 months ago

Mirum Pharmaceuticals Press release: M&A Announcement


Mirum Pharmaceuticals Slides: M&A Announcement

Dec 8, 2025, 8:30 AM EST - 7 months ago

Mirum Pharmaceuticals Slides: M&A Announcement


Mirum Pharma to buy Bluejay Therapeutics for up to $820 million

Dec 8, 2025, 8:05 AM EST - 7 months ago

Mirum Pharma to buy Bluejay Therapeutics for up to $820 million


Mirum Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

Mirum Pharmaceuticals Earnings Call Transcript: Q3 2025


Mirum Pharmaceuticals Quarterly report: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

Mirum Pharmaceuticals Quarterly report: Q3 2025


Mirum Pharmaceuticals Earnings release: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

Mirum Pharmaceuticals Earnings release: Q3 2025


Mirum Pharmaceuticals Slides: Corporate presentation

Nov 4, 2025, 4:00 PM EST - 8 months ago

Mirum Pharmaceuticals Slides: Corporate presentation


Mirum Pharmaceuticals Slides: Corporate Presentation

Nov 3, 2025, 6:00 PM EST - 8 months ago

Mirum Pharmaceuticals Slides: Corporate Presentation


Mirum Pharmaceuticals Slides: Corporate presentation

Sep 8, 2025, 7:00 AM EDT - 10 months ago

Mirum Pharmaceuticals Slides: Corporate presentation


Mirum Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 11 months ago

Mirum Pharmaceuticals Earnings Call Transcript: Q2 2025


Mirum Pharmaceuticals Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 11 months ago

Mirum Pharmaceuticals Quarterly report: Q2 2025


Mirum Pharmaceuticals Earnings release: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 11 months ago

Mirum Pharmaceuticals Earnings release: Q2 2025


Mirum Pharmaceuticals Slides: Corporate Presentation

Aug 6, 2025, 4:00 PM EDT - 11 months ago

Mirum Pharmaceuticals Slides: Corporate Presentation


Mirum Pharmaceuticals Earnings Call Transcript: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Mirum Pharmaceuticals Earnings Call Transcript: Q1 2025


Mirum Pharmaceuticals Quarterly report: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Mirum Pharmaceuticals Quarterly report: Q1 2025


Mirum Pharmaceuticals Earnings release: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Mirum Pharmaceuticals Earnings release: Q1 2025


Mirum Pharmaceuticals Slides: Corporate Presentation

May 7, 2025, 7:00 AM EDT - 1 year ago

Mirum Pharmaceuticals Slides: Corporate Presentation


Mirum's LIVMARLI Now FDA Approved in Tablet Formulation

Apr 14, 2025, 8:30 AM EDT - 1 year ago

Mirum's LIVMARLI Now FDA Approved in Tablet Formulation


Mirum Pharmaceuticals Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Mirum Pharmaceuticals Proxy statement: Proxy Filing


Mirum Pharmaceuticals Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Mirum Pharmaceuticals Proxy statement: Proxy Filing


Mirum Pharmaceuticals Slides: Corporate presentation

Apr 14, 2025, 7:00 AM EDT - 1 year ago

Mirum Pharmaceuticals Slides: Corporate presentation


LIVMARLI Now Approved in Japan for ALGS and PFIC

Mar 27, 2025, 8:30 AM EDT - 1 year ago

LIVMARLI Now Approved in Japan for ALGS and PFIC


Mirum Pharmaceuticals Earnings Call Transcript: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

Mirum Pharmaceuticals Earnings Call Transcript: Q4 2024


Mirum Pharmaceuticals Annual report: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

Mirum Pharmaceuticals Annual report: Q4 2024


Mirum Pharmaceuticals Earnings release: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

Mirum Pharmaceuticals Earnings release: Q4 2024


Mirum Pharmaceuticals Slides: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

Mirum Pharmaceuticals Slides: Q4 2024


US FDA approves Mirum Pharma's genetic disorder drug

Feb 21, 2025, 12:01 PM EST - 1 year ago

US FDA approves Mirum Pharma's genetic disorder drug


Mirum Pharmaceuticals Slides: Corporate Presentation

Jan 12, 2025, 7:00 PM EST - 1 year ago

Mirum Pharmaceuticals Slides: Corporate Presentation


Mirum Pharmaceuticals Slides: Corporate presentation

Dec 3, 2024, 7:00 AM EST - 1 year ago

Mirum Pharmaceuticals Slides: Corporate presentation


OffHisGame88
OffHisGame88 Jul. 4 at 2:39 PM
$MIRM seems interesting although I hate chasing biotech. Best to buy after a trial fail.
1 · Reply
Alpha_Ascendant
Alpha_Ascendant Jul. 4 at 11:29 AM
$MIRM Up 188% since my first report, this biotech is performing, building a liver disease franchise with a clutch of approved drugs while promising pipeline candidates --Volixibat, MRM-3379, Brelovitug, Zilurgisertib-- quietly stalk endpoints. $INCY ti.e-up and Bluejay acquisition a plus: https://seekingalpha.com/article/4919805-mirm-this-liver-disease-juggernaut-just-broadened-its-portfolio
0 · Reply
WAJeff
WAJeff Jul. 2 at 8:54 PM
$MIRM $125.75 ath
0 · Reply
IN0V8
IN0V8 Jul. 2 at 6:25 PM
$MIRM JP Morgan raises target price to $125 from $115
1 · Reply
LMXPERTEN
LMXPERTEN Jul. 2 at 1:50 PM
$MIRM so strong. Shaking the tree for losers.
0 · Reply
Hollywood_1
Hollywood_1 Jun. 29 at 1:33 AM
$MIRM another $XBI namd breaking out
0 · Reply
Doozio
Doozio Jun. 27 at 4:54 PM
👀 $MIRM $MEI da huckleberries r thru da $$$ as up da Roger yo go ENTA 🐒🍌🧠⏰♾️
0 · Reply
Home_Skillet
Home_Skillet Jun. 27 at 5:13 AM
$MIRM I still think we are undervalued been holding the bag since 22$ a share! Think we are heading North of 165$….
0 · Reply
CH_Expat
CH_Expat Jun. 26 at 6:47 PM
$MIRM Jesus Christ, I remember the duscussions which one is better, this or $ALBO. Case closed I would say. I was in ALBO BO and made my 70%, but most shareholders got just fckd there.
2 · Reply
WAJeff
WAJeff Jun. 26 at 3:00 PM
Had some $MIRM sell at $120, $123.10 ath
0 · Reply
LMXPERTEN
LMXPERTEN Jun. 26 at 2:45 PM
$MIRM bo in the making?
0 · Reply
LMXPERTEN
LMXPERTEN Jun. 26 at 2:26 PM
$MIRM 121
0 · Reply
Datum
Datum Jun. 25 at 3:08 PM
$MIRM remarkable. Anyone have an updated revenue estimate for TAM?
0 · Reply
WAJeff
WAJeff Jun. 25 at 2:47 PM
$MIRM $119.49 ath
1 · Reply
LMXPERTEN
LMXPERTEN Jun. 25 at 2:15 PM
$MIRM 118 😬
0 · Reply
WAJeff
WAJeff Jun. 24 at 4:58 PM
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Jun. 21 at 12:04 PM
1 · Reply
justiceforb_85
justiceforb_85 Jun. 21 at 2:08 AM
$MIRM wondering how much volixibat and zilurgisertib would add to the current valuation?
2 · Reply
TrendEdgeLogan
TrendEdgeLogan Jun. 20 at 6:26 PM
$MIRM $6.28B mc founder-led $XBI name now quietly making an ATH on volume following a pullback to the 40-week SMA in early June. - Pct of all funds in long-term uptrend at record highs - Short squeeze underway as short float % hits 3-year lows of 12.5%. PLENTY of fuel remaining AI Consult is BULLISH with a BUY recommendation on pullbacks to the 10-week SMA, with a price target of $140.00 TrendEdge.app/asset/MIRM
0 · Reply
paweltrader
paweltrader Jun. 19 at 12:21 AM
$264K out of $MIRM. SVP Howe sold 3k shares. Jun 17 https://watch4insider.com/filing/0001974200-26-000009 Get alerted the minute insiders file → watch4insider.com
0 · Reply
LMXPERTEN
LMXPERTEN Jun. 18 at 1:47 PM
$MIRM bam!!!
0 · Reply
LMXPERTEN
LMXPERTEN Jun. 15 at 10:30 PM
$MIRM i honestly believe we have left low 90s for the last time.
0 · Reply